Steven D. Sonenreich
CIK: 0002147313
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)1 (100.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BSEM
BioStem Technologies, Inc.
Director
Discretionary Trading P&L
Holdings
About SONENREICH STEVEN D
SONENREICH STEVEN D (SEC CIK 0002147313) files insider reports with the SEC as Director of BioStem Technologies, Inc. (BSEM).
Signal8 holds 2 ownership filings by SONENREICH STEVEN D (1 Form 3, 1 Form 4), filed between Aug 14, 2026 and Aug 28, 2026. Those filings report 1 transaction, the latest on Aug 27, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on SONENREICH STEVEN D's filings is in POMPANO BEACH, FL.
Recent filings by SONENREICH STEVEN D
- Aug 27, 2026: Option exercise of BSEM shares (Form 4, code M).
Other insiders filing for BioStem Technologies, Inc. (BSEM)
- SMITH-VAN VURST ANDREW, Chief Operating Officer
- Matuszewski Jason, Chief Executive Officer
- POE BRANDON, Chief Financial Officer
- WARRINGTON KENNETH HOWARD JR, Director
- FORTUNATO MICHAEL A, Chief Accounting Officer
- HASSETT BARRY, Chief Commercial Officer